Aman Chauhan, Leader of Neuroendocrine Cancer Program at the Sylvester Comprehensive Cancer Center, shared a post on X:
“Had a wonderful morning at the 2025 Design and Management of Cancer Trials Course with 500–600 attendees and an outstanding lineup of speakers.
I had the chance to present on one of my favorite topics: Theranostic Drug Development. What an exciting time to be advancing early-phase therapeutics in radiopharmaceuticals!
Register here to access recorded lectures as well as to tune in to next weeks lectures.”
More posts featuring Aman Chauhan.
